Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT04574856 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04574856
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-04
- Primary completion
- 2026-11-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.